TrialArthritis & rheumatology (Hoboken, N.J.)2022

Nintedanib in Patients With Systemic Sclerosis-Associated Interstitial Lung Disease: Subgroup Analyses by Autoantibody Status and Modified Rodnan Skin Thickness Score.

Masataka Kuwana et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.